Clinical Trials Browser

Leiomyosarcoma × cabozantinib × Clear all

NCT04200443 2026-01-05

Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Phase 2 Active not recruiting

Leiomyosarcoma, Sarcoma